164 related articles for article (PubMed ID: 36568503)
1. Recent progress in drying technologies for improving the stability and delivery efficiency of biopharmaceuticals.
Emami F; Keihan Shokooh M; Mostafavi Yazdi SJ
J Pharm Investig; 2023; 53(1):35-57. PubMed ID: 36568503
[TBL] [Abstract][Full Text] [Related]
2. Drying Technologies for the Stability and Bioavailability of Biopharmaceuticals.
Emami F; Vatanara A; Park EJ; Na DH
Pharmaceutics; 2018 Aug; 10(3):. PubMed ID: 30126135
[TBL] [Abstract][Full Text] [Related]
3. Spray Freeze Drying of Biologics: A Review and Applications for Inhalation Delivery.
Farinha S; Sá JV; Lino PR; Galésio M; Pires J; Rodrigues MÂ; Henriques J
Pharm Res; 2023 May; 40(5):1115-1140. PubMed ID: 36456666
[TBL] [Abstract][Full Text] [Related]
4. Solid Dosage Forms of Biopharmaceuticals in Drug Delivery Systems Using Sustainable Strategies.
Costa C; Casimiro T; Corvo ML; Aguiar-Ricardo A
Molecules; 2021 Dec; 26(24):. PubMed ID: 34946733
[TBL] [Abstract][Full Text] [Related]
5. Effect of Particle Formation Process on Characteristics and Aerosol Performance of Respirable Protein Powders.
Brunaugh AD; Wu T; Kanapuram SR; Smyth HDC
Mol Pharm; 2019 Oct; 16(10):4165-4180. PubMed ID: 31448924
[TBL] [Abstract][Full Text] [Related]
6. Biopharmaceutical powders: particle formation and formulation considerations.
Maa YF; Prestrelski SJ
Curr Pharm Biotechnol; 2000 Nov; 1(3):283-302. PubMed ID: 11469385
[TBL] [Abstract][Full Text] [Related]
7. Innovative Drying Technologies for Biopharmaceuticals.
Sharma A; Khamar D; Cullen S; Hayden A; Hughes H
Int J Pharm; 2021 Nov; 609():121115. PubMed ID: 34547393
[TBL] [Abstract][Full Text] [Related]
8. Formulating monoclonal antibodies as powders for reconstitution at high concentration using spray-drying: Trehalose/amino acid combinations as reconstitution time reducing and stability improving formulations.
Massant J; Fleurime S; Batens M; Vanhaerents H; Van den Mooter G
Eur J Pharm Biopharm; 2020 Nov; 156():131-142. PubMed ID: 32882422
[TBL] [Abstract][Full Text] [Related]
9. Characterization of excipient enhanced growth (EEG) tobramycin dry powder aerosol formulations.
Hassan A; Farkas D; Longest W; Hindle M
Int J Pharm; 2020 Dec; 591():120027. PubMed ID: 33130220
[TBL] [Abstract][Full Text] [Related]
10. Rapid Room-Temperature Aerosol Dehydration Versus Spray Drying: A Novel Paradigm in Biopharmaceutical Drying Technologies.
Poozesh S; Mezhericher M; Pan Z; Chaudhary U; Manikwar P; Stone HA
J Pharm Sci; 2024 Apr; 113(4):974-981. PubMed ID: 37802368
[TBL] [Abstract][Full Text] [Related]
11. Drying technology strategies for colon-targeted oral delivery of biopharmaceuticals.
Vass P; Démuth B; Hirsch E; Nagy B; Andersen SK; Vigh T; Verreck G; Csontos I; Nagy ZK; Marosi G
J Control Release; 2019 Feb; 296():162-178. PubMed ID: 30677436
[TBL] [Abstract][Full Text] [Related]
12. Protein inhalation powders: spray drying vs spray freeze drying.
Maa YF; Nguyen PA; Sweeney T; Shire SJ; Hsu CC
Pharm Res; 1999 Feb; 16(2):249-54. PubMed ID: 10100310
[TBL] [Abstract][Full Text] [Related]
13. How spray drying processing and solution composition can affect the mAbs stability in reconstituted solutions for subcutaneous injections. Part II: Exploring each protein stabilizer effect.
Barcelo-Chong CM; Filipe V; Nakach M; Inês Ré M
Int J Pharm; 2024 Apr; 655():124014. PubMed ID: 38513817
[TBL] [Abstract][Full Text] [Related]
14. Excipients in freeze-dried biopharmaceuticals: Contributions toward formulation stability and lyophilisation cycle optimisation.
Bjelošević M; Zvonar Pobirk A; Planinšek O; Ahlin Grabnar P
Int J Pharm; 2020 Feb; 576():119029. PubMed ID: 31953087
[TBL] [Abstract][Full Text] [Related]
15. Effects of drying method and excipient on the structure and physical stability of protein solids: Freeze drying vs. spray freeze drying.
Mutukuri TT; Wilson NE; Taylor LS; Topp EM; Zhou QT
Int J Pharm; 2021 Feb; 594():120169. PubMed ID: 33333176
[TBL] [Abstract][Full Text] [Related]
16. The influence of lysozyme on mannitol polymorphism in freeze-dried and spray-dried formulations depends on the selection of the drying process.
Grohganz H; Lee YY; Rantanen J; Yang M
Int J Pharm; 2013 Apr; 447(1-2):224-30. PubMed ID: 23500620
[TBL] [Abstract][Full Text] [Related]
17. Spray-Dried and Spray-Freeze-Dried Powder Formulations of an Anti-Interleukin-4Rα Antibody for Pulmonary Delivery.
Pan HW; Seow HC; Lo JCK; Guo J; Zhu L; Leung SWS; Zhang C; Lam JKW
Pharm Res; 2022 Sep; 39(9):2291-2304. PubMed ID: 35879500
[TBL] [Abstract][Full Text] [Related]
18. Analytical Techniques for Structural Characterization of Proteins in Solid Pharmaceutical Forms: An Overview.
Bolje A; Gobec S
Pharmaceutics; 2021 Apr; 13(4):. PubMed ID: 33920461
[TBL] [Abstract][Full Text] [Related]
19. Characterization of spray dried powders with nucleic acid-containing PEI nanoparticles.
Keil TWM; Feldmann DP; Costabile G; Zhong Q; da Rocha S; Merkel OM
Eur J Pharm Biopharm; 2019 Oct; 143():61-69. PubMed ID: 31445157
[TBL] [Abstract][Full Text] [Related]
20. Manufacturing of High-Concentration Monoclonal Antibody Formulations via Spray Drying-the Road to Manufacturing Scale.
Gikanga B; Turok R; Hui A; Bowen M; Stauch OB; Maa YF
PDA J Pharm Sci Technol; 2015; 69(1):59-73. PubMed ID: 25691715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
